Cargando…

Women’s self-reported experiences using misoprostol obtained from drug sellers: a prospective cohort study in Lagos State, Nigeria

OBJECTIVES: This study aimed to assess the safety and effectiveness of self-managed misoprostol abortions obtained outside of the formal health system in Lagos State, Nigeria. DESIGN: This was a prospective cohort study among women using misoprostol-containing medications purchased from drug sellers...

Descripción completa

Detalles Bibliográficos
Autores principales: Stillman, Melissa, Owolabi, Onikepe, Fatusi, Adesegun O, Akinyemi, Akanni I, Berry, Amanda L, Erinfolami, Temitope P, Olagunju, Olalekan S, Väisänen, Heini, Bankole, Akinrinola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7223139/
https://www.ncbi.nlm.nih.gov/pubmed/32376752
http://dx.doi.org/10.1136/bmjopen-2019-034670
_version_ 1783533703962558464
author Stillman, Melissa
Owolabi, Onikepe
Fatusi, Adesegun O
Akinyemi, Akanni I
Berry, Amanda L
Erinfolami, Temitope P
Olagunju, Olalekan S
Väisänen, Heini
Bankole, Akinrinola
author_facet Stillman, Melissa
Owolabi, Onikepe
Fatusi, Adesegun O
Akinyemi, Akanni I
Berry, Amanda L
Erinfolami, Temitope P
Olagunju, Olalekan S
Väisänen, Heini
Bankole, Akinrinola
author_sort Stillman, Melissa
collection PubMed
description OBJECTIVES: This study aimed to assess the safety and effectiveness of self-managed misoprostol abortions obtained outside of the formal health system in Lagos State, Nigeria. DESIGN: This was a prospective cohort study among women using misoprostol-containing medications purchased from drug sellers. Three telephone-administered surveys were conducted over 1 month. SETTING: Data were collected in 2018 in six local government areas in Lagos State. PARTICIPANTS: Drug sellers attempted to recruit all women who purchased misoprostol-containing medication. To remain in the study, participants had to be female and aged 18–49, and had to have purchased the medication for the purpose of abortion. Of 501 women initially recruited, 446 were eligible for the full study, and 394 completed all three surveys. PRIMARY AND SECONDARY OUTCOME MEASURES: Using self-reported measures, we assessed the quality of information provided by drug sellers; the prevalence of potential complications; and the proportion with completed abortions. RESULTS: Although drug sellers provided inadequate information about the pills, 94% of the sample reported a complete abortion without surgical intervention about 1 month after taking the medication. Assuming a conservative scenario where all individuals lost to follow-up had failed terminations, the completion rate dropped to 87%. While 86 women reported physical symptoms suggestive of complications, only six of them reported wanting or needing health facility care and four subsequently obtained care. CONCLUSIONS: Drug sellers are an important source of medical abortion in this setting. Despite the limitations of self-report, many women appear to have effectively self-administered misoprostol. Additional research is needed to expand the evidence on the safety and effectiveness of self-use of misoprostol for abortion in restrictive settings, and to inform approaches that support the health and well-being of people who use this method of abortion.
format Online
Article
Text
id pubmed-7223139
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-72231392020-05-15 Women’s self-reported experiences using misoprostol obtained from drug sellers: a prospective cohort study in Lagos State, Nigeria Stillman, Melissa Owolabi, Onikepe Fatusi, Adesegun O Akinyemi, Akanni I Berry, Amanda L Erinfolami, Temitope P Olagunju, Olalekan S Väisänen, Heini Bankole, Akinrinola BMJ Open Global Health OBJECTIVES: This study aimed to assess the safety and effectiveness of self-managed misoprostol abortions obtained outside of the formal health system in Lagos State, Nigeria. DESIGN: This was a prospective cohort study among women using misoprostol-containing medications purchased from drug sellers. Three telephone-administered surveys were conducted over 1 month. SETTING: Data were collected in 2018 in six local government areas in Lagos State. PARTICIPANTS: Drug sellers attempted to recruit all women who purchased misoprostol-containing medication. To remain in the study, participants had to be female and aged 18–49, and had to have purchased the medication for the purpose of abortion. Of 501 women initially recruited, 446 were eligible for the full study, and 394 completed all three surveys. PRIMARY AND SECONDARY OUTCOME MEASURES: Using self-reported measures, we assessed the quality of information provided by drug sellers; the prevalence of potential complications; and the proportion with completed abortions. RESULTS: Although drug sellers provided inadequate information about the pills, 94% of the sample reported a complete abortion without surgical intervention about 1 month after taking the medication. Assuming a conservative scenario where all individuals lost to follow-up had failed terminations, the completion rate dropped to 87%. While 86 women reported physical symptoms suggestive of complications, only six of them reported wanting or needing health facility care and four subsequently obtained care. CONCLUSIONS: Drug sellers are an important source of medical abortion in this setting. Despite the limitations of self-report, many women appear to have effectively self-administered misoprostol. Additional research is needed to expand the evidence on the safety and effectiveness of self-use of misoprostol for abortion in restrictive settings, and to inform approaches that support the health and well-being of people who use this method of abortion. BMJ Publishing Group 2020-05-05 /pmc/articles/PMC7223139/ /pubmed/32376752 http://dx.doi.org/10.1136/bmjopen-2019-034670 Text en © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Global Health
Stillman, Melissa
Owolabi, Onikepe
Fatusi, Adesegun O
Akinyemi, Akanni I
Berry, Amanda L
Erinfolami, Temitope P
Olagunju, Olalekan S
Väisänen, Heini
Bankole, Akinrinola
Women’s self-reported experiences using misoprostol obtained from drug sellers: a prospective cohort study in Lagos State, Nigeria
title Women’s self-reported experiences using misoprostol obtained from drug sellers: a prospective cohort study in Lagos State, Nigeria
title_full Women’s self-reported experiences using misoprostol obtained from drug sellers: a prospective cohort study in Lagos State, Nigeria
title_fullStr Women’s self-reported experiences using misoprostol obtained from drug sellers: a prospective cohort study in Lagos State, Nigeria
title_full_unstemmed Women’s self-reported experiences using misoprostol obtained from drug sellers: a prospective cohort study in Lagos State, Nigeria
title_short Women’s self-reported experiences using misoprostol obtained from drug sellers: a prospective cohort study in Lagos State, Nigeria
title_sort women’s self-reported experiences using misoprostol obtained from drug sellers: a prospective cohort study in lagos state, nigeria
topic Global Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7223139/
https://www.ncbi.nlm.nih.gov/pubmed/32376752
http://dx.doi.org/10.1136/bmjopen-2019-034670
work_keys_str_mv AT stillmanmelissa womensselfreportedexperiencesusingmisoprostolobtainedfromdrugsellersaprospectivecohortstudyinlagosstatenigeria
AT owolabionikepe womensselfreportedexperiencesusingmisoprostolobtainedfromdrugsellersaprospectivecohortstudyinlagosstatenigeria
AT fatusiadeseguno womensselfreportedexperiencesusingmisoprostolobtainedfromdrugsellersaprospectivecohortstudyinlagosstatenigeria
AT akinyemiakannii womensselfreportedexperiencesusingmisoprostolobtainedfromdrugsellersaprospectivecohortstudyinlagosstatenigeria
AT berryamandal womensselfreportedexperiencesusingmisoprostolobtainedfromdrugsellersaprospectivecohortstudyinlagosstatenigeria
AT erinfolamitemitopep womensselfreportedexperiencesusingmisoprostolobtainedfromdrugsellersaprospectivecohortstudyinlagosstatenigeria
AT olagunjuolalekans womensselfreportedexperiencesusingmisoprostolobtainedfromdrugsellersaprospectivecohortstudyinlagosstatenigeria
AT vaisanenheini womensselfreportedexperiencesusingmisoprostolobtainedfromdrugsellersaprospectivecohortstudyinlagosstatenigeria
AT bankoleakinrinola womensselfreportedexperiencesusingmisoprostolobtainedfromdrugsellersaprospectivecohortstudyinlagosstatenigeria